Follow on Google News News By Tag * Drug * Drugs * Drug Discovery * Drug Development * Discovery And Development * M3d * Modern Drug * Pharmacokinetics * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Dr. Stephen Burley, SGX Pharmaceuticals–Keynote speaker at 3rd Modern Drug Discovery & DevelopmentStephen Burley, at SGX Pharmaceuticals to give Keynote talk at Drug Design & Lead Discovery conference– 1 of 6 tracks at 3rd Modern Drug Discovery & Development Summit on Nov 28-30, 2007 in San Fran
By: GTCbio Dr. Burley’s presentation will cover fragment-based discovery of selective, orally bioavailable tyrosine kinase inhibitors for targeted treatment of human cancers with examples from SGX’s FAST™ (Fragments of Active Structures) platform. The fragment-based drug discovery platform utilizes high-throughput X-ray crystallography for lead identification/ The 3rd Modern Drug Discovery & Development Summit features over 150 speakers participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genomics and Genetics. For more information, visit www.gtcbio.com. # # # ABOUT GTCbio GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002. Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com Website: www.gtcbio.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|